OxyContin maker Purdue Pharma's settlement, by the numbers
OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a n…


Glideslope AI-powered market news
No market stories in the last 7 days. The latest coverage is below.

No scored stories in the last 7 days.
| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a n…

'Putting countless lives at risk'

OxyContin maker to be replaced by new company aiming to combat opioid crisis as legal settlement takes effect. OxyContin maker Purdue Pharma is set to be disso…

Purdue Pharma was sentenced Tuesday to $5.5 billion in fines and penalties on charges of deceiving regulators and paying doctors to boost opioid sales.

Under settlement, Sackler family will pay state, local and Native American tribal governments, individual victims and others. Sign up for the Breaking News US…

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the U.S. government

Indiana test road delivers 190 Kilowatts to a prototype Cummins class 8 electric vehicle at 65 MPH The post Purdue achieves first U.S. wireless charging of hea…

A judge is set to explain why he's approving a plan for OxyContin maker Purdue Pharma to settle thousands of lawsuits over the toll of opioids

A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement.

The new agreement replaces one the US Supreme Court rejected last year, finding it would have improperly protected members of the family against future lawsuit…

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, lo…

A federal bankruptcy court judge said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that…
The deal could end a years-long legal battle over the OxyContin maker's role in the US opioid crisis.

The company that makes OxyContin, members of the Sackler family who own it and many groups that sued over its role in the opioid crisis are asking a judge to a…

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids
A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma's plan to settle thousands of law…

More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler family over the opioid crisis, offic…

The $7.4 billion payment is intended to resolve claims that the drugmaker's pain medication OxyContin caused a nationwide opioid addiction crisis.
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case
. Operated out of Purdue Polytechnic Institute, the offering includes an "earn and learn" incentive for prospective students, who can make money while attendin…

The Sackler family will pay the vast majority of the settlement - a total of $6.5 billion over 15 years.
The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE